Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hospital risk scores aim to spot sepsis and sudden deterioration earlier

NCT ID NCT06779617

Knowledge-focused Sponsor: University of Maryland, Baltimore Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing two new risk scores that predict a patient's chance of developing sepsis or experiencing a sudden decline (like cardiac arrest or death) within the next 4 hours. The scores give a simple 1-to-4 color-coded risk level to alert hospital staff. The goal is to see if providing these scores helps doctors and nurses check on high-risk patients sooner. The trial will involve about 150,000 adult patients across multiple hospitals in the University of Maryland Medical System.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
clinical decision support tool (SEPSys Score and RESCUE Score)
What this could lead to
If successful, this could help hospitals identify patients at risk of sepsis or sudden decline earlier, potentially saving lives.
What could go wrong
This is a large pragmatic trial testing a prediction tool, not a treatment. The scores may not improve outcomes or could lead to unnecessary alarms.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 150,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2026

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Hospital Unit Inclusion Criteria: * Units are part of a member hospital of the University of Maryland Medical System (UMMS) * Units treat inpatient patients * Units agree to participate in the study General Encounter Inclusion Criteria: * Encounter is on a participating inpatient unit * Encounter is associated with a bedded patient in the hospital * Encounter is associated with an adult (at least 18 years of age at time of admission) Additional SEPSys Encounter Inclusion Criteria: • Encounter has a SEPSys Score Additional RESCUE Encounter Inclusion Criteria: • Encounter has a RESCUE Score Exclusion Criteria: Hospital Unit Exclusion Criteria: * Unit treats exclusively outpatients or is located in an outpatient setting * Unit treats primarily or exclusively pediatric patients (patients under the age of 18 years old) * Unit treats exclusively psychiatric patients Additional SEPSys Encounter Exclusion Criteria: * Encounter is with OB for a normal delivery and the patient has yet to give birth. This encounter can become eligible once the patient has given birth. * Encounter is admitted with a diagnosis of sepsis * Sepsis was already diagnosed during the encounter This encounter will have been eligible until the patient began showing clinical signs or symptoms of sepsis or received a diagnosis of sepsis. Once they have a diagnosis or clinical signs or symptoms of sepsis, their SEPSys Score will no longer be updated. Data will continue to be collected on time of laboratory orders and treatments. Additional RESCUE Encounter Exclusion Criteria: • Encounter is admitted with a high RESCUE Score (RESCUE Score of 4)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Patient deterioration are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

infectious disease with sepsis Sepsis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Patient deterioration Sepsis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    8 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University of Maryland Baltimore Washington Medical Center

    NOT_YET_RECRUITING

    Glen Burnie, Maryland, 21061, United States

  • University of Maryland Capital Region Medical Center

    RECRUITING

    Largo, Maryland, 20774, United States

  • University of Maryland Charles Regional Medical Center

    NOT_YET_RECRUITING

    La Plata, Maryland, 20646, United States

  • University of Maryland Medical Center

    NOT_YET_RECRUITING

    Baltimore, Maryland, 21201, United States

  • University of Maryland Medical Center - Midtown

    RECRUITING

    Baltimore, Maryland, 21201, United States

  • University of Maryland Shore Medical Center

    NOT_YET_RECRUITING

    Easton, Maryland, 21601, United States

  • University of Maryland St. Joseph Medical Center

    NOT_YET_RECRUITING

    Towson, Maryland, 21204, United States

  • University of Maryland Upper Chesapeake Medical Center

    NOT_YET_RECRUITING

    Bel Air, Maryland, 21014, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.